Back to search

National and Kapodistrian University of Athens

Η πιπερακιλλίνη - ταζομπακτάμη στη θεραπεία μοντέλου πειραματικού εμπυήματος από πολυανθεκτική pseudomonas aeruginasa: ανοσοπαρέμβση με κλαριθρομυκίνη

Abstract

dc:description

Objective: To assess the efficacy of co-administration of clarithromycin and piperacillin/tazobactam in experimental thoracic empyema caused by multidrug-resistant isolate of Pseudomonas aeruginosa.Design: 40 white New Zealand male rabbits were studied. They were divided into four groups of treatment (A, B, C, D) of 10 animals each.Setting: Acute infection as bacteremia was induced after the injection of the prepared inoculums of the isolate in the pleural cavity of the animals. Treatment was administered as single shots only on the first day of infection at the animals which were randomly assigned into four groups. This was done in accordance with previous studies of our group where single intravenous doses allowed to define a role of clarithromycin on the modulation of host response.Groups: A as controls; B-D therapy initiation as follows: B: clarithromycin as monotherapy C: piperacillin/tazobactam as monotherapy D: therapy with both agents clarithromycin and piperacillin/tazobactamMeasurements: The number of bacteria in the pleural fluid cultures were lower for group D compared with the other groups on day 5 (p:0.015, p:0.040, p:0.046 compared with groups A, B and C respectively). This was accompanied by lower growth of P.aeruginosa in the lung on sacrifice in animals of group D compared with group A (p:0.027). However bacterial growth in the lung of groups B and C did not differ from group A. Bacterial growth in the liver was lower in groups B, C and D compared with group A (p:0.001, p:0.001 p:0.002 respectively). Trying to delineate a probable immunmodulatory effect of clarithromycin on the host we compared the rate of apoptosis of mononuclear cells between groups. There were no differences found regarding apoptosis of mononuclear cells; however TNFα of the pleural fluid sampled on day 5 was lower in group D than in group C (p<0.0001). In addition, when centrifuged pleural fluid sampled on day 5 was incubated with U937 monocytes, samples from group D stimulated much lower concentrations of TNFα and of IL-6 than samples from group C (p:0.022 and p:0.037 respectively). Conclusions: In conclusion, the present study revealed that administration of clarithromycin in experimental empyema by multidrug-resistant P.aeruginosa decreased bacterial growth in the pleural fluid and in tissues, an effect enhanced by the co-administration of piperacillin/tazobactam. These results create new perspectives for the management of hospital-acquired lung infections by multidrug-resistant P.aeruginosa.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsovolou, Eirini-Charikleia
  • Τσοβόλου, Ειρήνη-Χαρίκλεια

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41425

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsovolou, Eirini-Charikleia; Τσοβόλου, Ειρήνη-Χαρίκλεια. Η πιπερακιλλίνη - ταζομπακτάμη στη θεραπεία μοντέλου πειραματικού εμπυήματος από πολυανθεκτική pseudomonas aeruginasa: ανοσοπαρέμβση με κλαριθρομυκίνη. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/41425